ICMR Recruitment 2024: Earn Up To ₹70,000/Month - Check Eligibility & Apply Now!
The Indian Council of Medical Research (ICMR) has opened applications for the role of Consultant (Scientific – Non-Medical) in its latest recruitment drive for 2024. With only one vacancy, this is a unique opportunity for qualified candidates to work on a significant project in the healthcare sector. The selected candidate will be stationed in Chennai and will receive a monthly salary of up to ₹70,000. Interested individuals can apply through the NIE Recruitment Portal before October 11, 2024.
Key Details for ICMR Recruitment 2024
Post Name and Vacancy
Eligibility and Age Limit
Desirable Skills:
Salary
The selected candidate will receive a monthly salary of ₹70,000.
Tenure and Posting
Duration: The role will extend up to July 31, 2025, with the possibility of an extension based on performance and project continuation.
Location: ICMR-NIE, Chennai
Project Details
The candidate will work on a Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Study aimed at evaluating the efficacy, immunogenicity, and safety of a Dengue Tetravalent Vaccine – "DengiAll" by Panacea Biotec Limited in healthy Indian adults.
Key Details for ICMR Recruitment 2024
Post Name and Vacancy
- Consultant (Scientific – Non-Medical)
- Number of Vacancies: 1
Eligibility and Age Limit
- Maximum Age Limit: 70 years
- Educational Qualification: Applicants should possess an M.Sc. in Statistics or Biostatistics along with experience in Research and Development and published papers.
Desirable Skills:
- Experience managing clinical trial-related data and large datasets
- Certification in ICH-GCP (International Conference on Harmonization – Good Clinical Practice)
- Proficiency in computer applications and statistical packages
Salary
The selected candidate will receive a monthly salary of ₹70,000.
Tenure and Posting
Duration: The role will extend up to July 31, 2025, with the possibility of an extension based on performance and project continuation.
Location: ICMR-NIE, Chennai
Project Details
The candidate will work on a Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Study aimed at evaluating the efficacy, immunogenicity, and safety of a Dengue Tetravalent Vaccine – "DengiAll" by Panacea Biotec Limited in healthy Indian adults.
Next Story